Abstract
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder. Worldwide, its prevalence is ~2% and its etiology is mostly unknown. Identifying biological factors contributing to OCD will elucidate underlying mechanisms and might contribute to improved treatment outcomes. Genomic studies of OCD are beginning to reveal long-sought risk loci, but >95% of the cases currently in analysis are of homogenous European ancestry. If not addressed, this Eurocentric bias will result in OCD genomic findings being more accurate for individuals of European ancestry than other ancestries, thereby contributing to health disparities in potential future applications of genomics. In this study protocol paper, we describe the Latin American Trans-ancestry INitiative for OCD genomics (LATINO, www.latinostudy.org). LATINO is a new network of investigators from across Latin America, the United States, and Canada who have begun to collect DNA and clinical data from 5,000 richly-phenotyped OCD cases of Latin American ancestry in a culturally sensitive and ethical manner. In this project, we will utilize trans-ancestry genomic analyses to accelerate the identification of OCD risk loci, fine-map putative causal variants, and improve the performance of polygenic risk scores in diverse populations. We will also capitalize on rich clinical data to examine the genetics of treatment response, biologically plausible OCD subtypes, and symptom dimensions. Additionally, LATINO will help elucidate the diversity of the clinical presentations of OCD across cultures through various trainings developed and offered in collaboration with Latin American investigators. We believe this study will advance the important goal of global mental health discovery and equity.
Competing Interest Statement
Dr. Storch discloses the following relationships: consultant for Biohaven Pharmaceuticals and Brainsway; Book royalties from Elsevier, Springer, American Psychological Association, Wiley, Oxford, Kingsley, and Guilford; Stock valued at less than $5000 from NView; Research support from NIH, IOCDF, Ream Foundation, and Texas Higher Education Coordinating Board. Dr. Zoghbi is a consultant for AstraZeneca. In the past 3 years, Dr. Rodriguez has been a consultant for Biohaven Pharmaceuticals and Osmind; received research grant support from Biohaven Pharmaceuticals; and received a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry. Dr. Arnold receives research grant support from Biohaven Pharmaceuticals and is a consultant for Headversity. Dr. Comer received royalties from Macmillan Learning. Dr. Goodman consults for Biohaven Pharmaceuticals and has received royalties from NView LLC.
Funding Statement
Data are being generated as part of the Ancestral Populations Network (APN), supported by the National Institute of Mental Health, USA: U01MH125050 (PI Crowley) and U01MH125062 (PI Storch). Dr. Zoghbi receives support from the NIMH (K23MH121669). Dr. Atkinson is supported by K01 MH121659, the Caroline Wiess Law Fund for Research in Molecular Medicine, and the ARCO Foundation Young Teacher-Investigator Fund at Baylor College of Medicine. Dr. Arnold receives funding from the Alberta Innovates Translational Health Chair in Child and Adolescent Mental Health. Dr. Comer receives research funding from NIH, NICHD, PCORI, SAMHSA, NSF, and FTX Foundation. Dr. Fontenelle is supported by the Conselho Nacional de Desenvolvimento Cientifico e. Tecnologico, Brazil (CNPq; Grant number 302526/2018-8); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Brazil (FAPERJ; Grant number CNE E−26/203.052/2017); D Or Institute of Research and Education, Brazil (IDOR; No grant number available); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES; No grant number available). Dr. Gonzalez-Barrios is supported by the NIH Scholar for Hispanic Clinical and Translational Research Education and Career Development (HCTRECD) program (R25MD007607). Dr. Zai is supported by the Academic Scholars Award at the Department of Psychiatry, University of Toronto. Dr. Miguel is supported by the National Institute of Developmental Psychiatry for Children and Adolescent (INPD) Grant: Fapesp 2014/50917-0.CNPq 465550/2014-2. Dr. Mattheisen is supported by U01MH125050. Dr. Rancourt receives support from the National Center for Complementary and Integrative Health (1R34AT010661-0). No funding bodies were involved in the study design and collection, analysis or interpretation of data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
LATINO was approved by the Baylor College of Medicine (BCM) Institutional Review Board (IRB) (Approval Number: H-49814) under the single IRB (sIRB) framework. BCM is the IRB of record for all US-based sites. Each site outside the US has received ethical approval from a local IRB.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos